RI S2532 | 2018 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on March 1 2018 - 25% progression, died in chamber
Action: 2018-05-31 - Committee recommends passage of Sub A
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 1 2018 - 25% progression, died in chamber
Action: 2018-05-31 - Committee recommends passage of Sub A
Text: Latest bill text (Introduced) [PDF]
Summary
Regulates prescription drug marketing by manufacturers using strategies offering various discounts to disguise costs of high priced drugs versus lower costs alternatives and makes discounts available to individuals without health insurance. Eff. 1/1/19.
Title
Prescription Drug Benefits--prescription Drug Marketing
Sponsors
| Sen. Joshua Miller [D] | Sen. Gayle Goldin [D] | Sen. Jeanine Calkin [D] | Sen. Adam Satchell [D] |
| Sen. Leonidas Raptakis [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-05-31 | Senate | Committee recommends passage of Sub A |
| 2018-05-25 | Senate | Scheduled for consideration (05/31/2018) |
| 2018-05-24 | Senate | Committee recommended Substitute A be held for further study |
| 2018-05-24 | Senate | Committee recommended indefinite postponement |
| 2018-05-18 | Senate | Scheduled for hearing and/or consideration (05/24/2018) |
| 2018-05-16 | Senate | Meeting postponed (05/17/2018) |
| 2018-05-11 | Senate | Scheduled for consideration |
| 2018-03-27 | Senate | Committee recommended measure be held for further study |
| 2018-03-12 | Senate | Scheduled for hearing and/or consideration (03/27/2018) |
| 2018-03-12 | Senate | Meeting postponed (03/13/2018) |
| 2018-03-09 | Senate | Scheduled for hearing and/or consideration |
| 2018-03-01 | Senate | Introduced, referred to Senate Health and Human Services |
